135 related articles for article (PubMed ID: 11516723)
1. Assays to predict the genotoxicity of the chromosomal mutagen etoposide -- focussing on the best assay.
Turner SD; Wijnhoven SW; Tinwell H; Lashford LS; Rafferty JA; Ashby J; Vrieling H; Fairbairn LJ
Mutat Res; 2001 Jun; 493(1-2):139-47. PubMed ID: 11516723
[TBL] [Abstract][Full Text] [Related]
2. Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses.
Ashby J; Tinwell H; Glover P; Poorman-Allen P; Krehl R; Callander RD; Clive D
Environ Mol Mutagen; 1994; 24(1):51-60. PubMed ID: 8050416
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro and in vivo assessment of genotoxic effects of etoposide and chlorothalonil by the comet assay.
Godard T; Fessard V; Huet S; Mourot A; Deslandes E; Pottier D; Hyrien O; Sichel F; Gauduchon P; Poul J
Mutat Res; 1999 Jul; 444(1):103-16. PubMed ID: 10477344
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic risk assessment of etoposide from mouse bone marrow.
Choudhury RC; Palo AK; Sahu P
J Appl Toxicol; 2004; 24(2):115-22. PubMed ID: 15052606
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vivo gene mutation with etoposide using Pig-a and PIGRET assays.
Yamamoto M; Wakata A
Mutat Res Genet Toxicol Environ Mutagen; 2016 Nov; 811():29-34. PubMed ID: 27931810
[TBL] [Abstract][Full Text] [Related]
6. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of gamma-radiation, mitomycin C, and etoposide in the Hprt and Tk genes of Tk(+/-) mice.
Dobrovolsky VN; Shaddock JG; Heflich RH
Environ Mol Mutagen; 2002; 39(4):342-7. PubMed ID: 12112386
[TBL] [Abstract][Full Text] [Related]
8. Genotoxic and mutagenic properties of Ni and NiO nanoparticles investigated by comet assay, γ-H2AX staining, Hprt mutation assay and ToxTracker reporter cell lines.
Åkerlund E; Cappellini F; Di Bucchianico S; Islam S; Skoglund S; Derr R; Odnevall Wallinder I; Hendriks G; Karlsson HL
Environ Mol Mutagen; 2018 Apr; 59(3):211-222. PubMed ID: 29243303
[TBL] [Abstract][Full Text] [Related]
9. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
Aratani Y; Andoh T; Koyama H
Mutat Res; 1996 Feb; 362(2):181-91. PubMed ID: 8596537
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity of several clinically used topoisomerase II inhibitors.
Boos G; Stopper H
Toxicol Lett; 2000 Jul; 116(1-2):7-16. PubMed ID: 10906417
[TBL] [Abstract][Full Text] [Related]
11. The clastogenicity of 4NQO is cell-type dependent and linked to cytotoxicity, length of exposure and p53 proficiency.
Brüsehafer K; Manshian BB; Doherty AT; Zaïr ZM; Johnson GE; Doak SH; Jenkins GJ
Mutagenesis; 2016 Mar; 31(2):171-80. PubMed ID: 26362870
[TBL] [Abstract][Full Text] [Related]
12. Induction of hprt gene mutations in splenic T-lymphocytes from the rat exposed in vivo to DNA methylating agents is correlated with formation of O6-methylguanine in bone marrow and not in the spleen.
Jansen JG; de Groot AJ; van Teijlingen CM; Tates AD; Vrieling H; van Zeeland AA
Carcinogenesis; 1996 Oct; 17(10):2183-91. PubMed ID: 8895487
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the weak in vivo micronucleus response of a genotoxic carcinogen, aristolochic acids.
Bhalli JA; Ding W; Shaddock JG; Pearce MG; Dobrovolsky VN; Heflich RH
Mutat Res; 2013 May; 753(2):82-92. PubMed ID: 23500662
[TBL] [Abstract][Full Text] [Related]
14. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies.
Shi J; Krsmanovic L; Bruce S; Kelly T; Paranjpe M; Szabo K; Arevalo M; Atta-Safoh S; Debelie F; LaForce MK; Sly J; Springer S
Environ Mol Mutagen; 2011 Dec; 52(9):711-20. PubMed ID: 21976072
[TBL] [Abstract][Full Text] [Related]
15. In vivo genotoxicity of a novel heterocyclic amine, aminobenzoazepinoquinolinone-derivative (ABAQ), produced by the Maillard reaction between glucose and l-tryptophan.
Totsuka Y; Watanabe T; Coulibaly S; Kobayashi S; Nishizaki M; Okazaki M; Hasei T; Wakabayashi K; Nakagama H
Mutat Res Genet Toxicol Environ Mutagen; 2014 Jan; 760():48-55. PubMed ID: 24333690
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the alkaline comet assay with the micronucleus test for genotoxicity monitoring using aquatic organisms.
Kim IY; Hyun CK
Ecotoxicol Environ Saf; 2006 Jul; 64(3):288-97. PubMed ID: 16026836
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity studies of a desealant solvent mixture, SR-51.
Oakes DJ; Ritchie HE; Woodman PD; Narup E; Moscova M; Picker K; Webster WS
Toxicol Ind Health; 2009 Feb; 25(1):5-13. PubMed ID: 19318500
[TBL] [Abstract][Full Text] [Related]
18. Validation of conditions for efficient detection of HPRT and APRT mutations in suspension-cultured Chinese hamster ovary cells.
Thompson LH; Fong S; Brookman K
Mutat Res; 1980 Feb; 74(1):21-36. PubMed ID: 7360155
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
Meng Q; Henderson RF; Chen T; Heflich RH; Walker DM; Bauer MJ; Reilly AA; Walker VE
Mutat Res; 1999 Aug; 429(1):107-25. PubMed ID: 10434027
[TBL] [Abstract][Full Text] [Related]
20. Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems.
Gupta RS; Bromke A; Bryant DW; Gupta R; Singh B; McCalla DR
Mutagenesis; 1987 May; 2(3):179-86. PubMed ID: 3325741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
